EUVIMEDEUVIMED entdecken
Crossref

Fluorinated multi-mechanism antimicrobial peptides for improved potency against multidrug-resistant bacterial infections

Luyang Gao, Chao Zhong, Qiqi Yu, Jingyi Zhu, Wenjing Xue, Jing Zou, Jiahui Wang, Ning Xu, Sanhu Gou, Yun Zhang, Hui Liu, Jingman Ni

Drug Resistance Updates · 2026-09 · 88 · 101448

DOI: 10.1016/j.drup.2026.101448 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Resistance Updates, 2026-09. Verfasst von Luyang Gao und 11 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pharmaceutics, School of Pharmacy, Key Laboratory of Preclinical Study for New Drugs of Gansu Province, School of Basic Medical Sciences…. Hauptthemen laut MEDLINE: Drug Resistance, Multiple, Bacterial, Anti-Bacterial Agents, Antimicrobial Peptides, Bacterial Infections. Die Arbeit nennt 51 Literaturangaben. Gefördert von: Chinese Academy of Medical Sciences Initiative for Innovative Medicine, Program for Changjiang Scholars and Innovative Research Team in University, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

AIMS: Antimicrobial peptides (AMPs) are promising alternatives to antibiotics; however, their development is often hampered by poor stability, safety concerns, and uncertain resistance risk. Therefore, this study aimed to develop new AMPs with enhanced stability, safety, and low resistance potential against multidrug-resistant bacteria. METHODS: A fluorination-based modification strategy was used to develop new AMPs, and their antimicrobial activity, stability, safety, mechanism, resistance development, and in vivo efficacy and safety were evaluated. RESULTS: A series of fluorinated AMPs was designed and synthesized, and Hrk8 was identified the lead candidate, which exhibited potent activity against multidrug-resistant bacteria, good stability and a favourable safety profile. Hrk8 operated via a multi-mechanism, including rapid membrane disruption, interference with intracellular processes, and species-specific transcriptional responses. In Escherichia coli, Hrk8 exposure was associated with widespread metabolic dysregulation reflecting systemic collapse of cellular homeostasis. In contrast, in methicillin-resistant Staphylococcus aureus, the transcriptional response suggested adaptive envelope remodelling and reduced virulence-associated regulatory programs. Consistent with this combined action, Hrk8 showed a low propensity to develop bacterial resistance and could limit the development of antibiotic resistance, while also exhibiting synergistic or additive antimicrobial activity and eradicating persister cells. Hrk8 achieved efficacy comparable to polymyxin B and vancomycin in mouse models of systemic infection, pneumonia and skin wound infection, but with a more favourable safety profile than polymyxin B. CONCLUSIONS: Fluorination effectively generated developable AMPs, resulting in Hrk8, which exhibited potent, broad-spectrum antimicrobial activity, low resistance potential, and promising therapeutic prospects. This approach provides a practical method to combat drug-resistant infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug Resistance, Multiple, BacterialAnti-Bacterial AgentsAntimicrobial PeptidesBacterial InfectionsAntimicrobial Cationic PeptidesAnimalsHumansMicrobial Sensitivity TestsHalogenationMethicillin-Resistant Staphylococcus aureusMiceEscherichia coli

Stichwörter der Autor:innen

Antimicrobial peptidesFluorinationMulti-mechanismMultidrug-resistant bacteriain vivo efficacy and safety

Substanzen

Anti-Bacterial AgentsAntimicrobial PeptidesAntimicrobial Cationic Peptides

Autor:innen und Institutionen

  • Institute of Pharmaceutics, School of Pharmacy, Key Laboratory of Preclinical Study for New Drugs of Gansu Province, School of Basic Medical Sciences, and Research Unit of Peptide Science, Chinese Academy of Medical Sci…

Förderung

  • Chinese Academy of Medical Sciences Initiative for Innovative Medicine
  • Program for Changjiang Scholars and Innovative Research Team in University
  • National Natural Science Foundation of China
  • Lanzhou University

Zitieren

APA

Gao, L., Zhong, C., Yu, Q., Zhu, J., Xue, W., Zou, J., Wang, J., Xu, N., Gou, S., Zhang, Y., Liu, H., & Ni, J. (2026). Fluorinated multi-mechanism antimicrobial peptides for improved potency against multidrug-resistant bacterial infections. Drug Resistance Updates, 88, 101448. https://doi.org/10.1016/j.drup.2026.101448

Vancouver

Gao L, Zhong C, Yu Q, Zhu J, Xue W, Zou J, et al. Fluorinated multi-mechanism antimicrobial peptides for improved potency against multidrug-resistant bacterial infections. Drug Resistance Updates. 2026;88:101448. doi:10.1016/j.drup.2026.101448

BibTeX
@article{Gao2026,
  author = {Gao, Luyang and Zhong, Chao and Yu, Qiqi and Zhu, Jingyi and Xue, Wenjing and Zou, Jing and Wang, Jiahui and Xu, Ning and Gou, Sanhu and Zhang, Yun and Liu, Hui and Ni, Jingman},
  title = {Fluorinated multi-mechanism antimicrobial peptides for improved potency against multidrug-resistant bacterial infections},
  journal = {Drug Resistance Updates},
  year = {2026},
  volume = {88},
  pages = {101448},
  doi = {10.1016/j.drup.2026.101448}
}
Kostenlos starten →